Skip to content

Opening book details…

About this Medicine article

Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways by Yang, Yun; Tian, Ziyin; Guo, Rui; Ren, Feng is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Yang, Yun; Tian, Ziyin; Guo, Rui; Ren, Feng
Publisher
Hindawi Limited; Hindawi Publishing Corporation; Austin TX: Landes Bioscience, 2008-2010; New York: 2011-; London: Hindawi (ISSN 1942-0900)
Published
2020
Field
Medicine (Health Sciences)

More by Yang, Yun; Tian, Ziyin; Guo, Rui; Ren, Feng

Browse all works by Yang, Yun; Tian, Ziyin; Guo, Rui; Ren, Feng